GatiShakti-NIP-NMP trinity: Catapulting India into the next stage of growth cycle

As India embarks on its journey of $5 trillion economy, the importance of more supply side initiatives cannot be undermined. In line with the concepts of completely in-house manufacturing such as “AtmaNirbhar Bharat” and “Make in India”, the government is intent to push infrastructure development at par with global standards for the overall success.

Various policy level initiatives being taken for infrastructure development in key sectors, especially in promotion of manufacturing sector, will lead to rapid urbanization and demographic transitions across states. For this, a host of infrastructure facilities will be required such as water, sanitation, power supply, transportation, digital, etc.

Streamlined logistics can boost growth

The logistics industry is reaping benefits from the rollout of the Pradhan Mantri Gati Shakti & technology adoption

The Indian logistics sector provides livelihood to more than 22 million people, and improving the sector will facilitate 10 per cent lower indirect logistics cost, which will spike 5 to 8 per cent in growth of exports. This will pave the way for a strong Indian economy backed by solid infrastructure.

Pradhan Mantri Gati Shakti & technology adoption

Artificial Intelligence: A smarter way to build smart cities

The challenges of developing brownfield cities are different from Greenfield, but common to both is the understanding that technologies like AI and IoT will be the cornerstone of realizing India’s aspirations of building ‘intelligent’ cities of tomorrow.

Artificial intelligence, or AI, a term that a few decades ago circled around in the realms of sci-fi and fantasy, is a reality today. The most evolved AI of our fantasy tales is often sentient machines scheming to take over the world. We are not there yet, and perhaps reality is far more benign than our imagination.

India’s pharma industry vital for world’s vaccination programme

India has also the largest number of FDA approved plants outside the US, nearly 2,050 WHO-GMP approved pharma plants, and a number of European Directorate of Quality Medicines (EDQM) approved plants with state of the art technology. India's pharma and medical devices industry, the 3rd largest producer of pharmaceutical products by volume and 14th largest by value, benefits from the economies of scale derived from the huge domestic and export market, cheap labour, and low-cost manufacturing.